A carregar...
Examining HSD3B1 as a possible biomarker to detect prostate cancer patients who are likely to progress on ADT
The Chemohormonal Therapy vs Androgen Ablation Randomized Trial for Extensive Disease in Prostate Cancer (CHAARTED) was a randomized phase III trial that evaluated the outcomes of men with metastatic prostate cancer who received castration with or without docetaxel. Patients from this trial were gen...
Na minha lista:
| Publicado no: | Cancer Biol Ther |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7515525/ https://ncbi.nlm.nih.gov/pubmed/32791030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2020.1796195 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|